Greedy? Hilarious battle for COVID-19 drug continues. The United States under President Donald Trump buys all Remdesivir COVID-19 drug and its subsequent three months of manufacturing.
The Trump administration says it has locked down nearly the entire supply of one of the only available anti-COVID-19 drugs from the manufacturer for the next several months.
Remdesivir is the first drug shown to help patients with COVID-19, though its impact is modest.
Hospitalized patients given the drug recovered four days faster than those given a placebo.
Preliminary results did not show that it saved lives, but the study is ongoing.
The U.S. Department of Health and Human Services stated Monday that it had secured half a million treatment courses of the antiviral drug from its manufacturer.
The U.S. pharmaceutical company Gilead Sciences, including 100% of the company’s production for July and 90% for August and September has been secured.
“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” HHS Secretary Alex Azar said.
This post was created with our nice and easy submission form. Create your post!
